Cell Biotech Co. Ltd Working Capital to Net Assets Ratio
Cell Biotech Co. Ltd working capital to net assets ratio. Cell Biotech Co. Ltd (049960) has a Working Capital to Net Assets ratio of 73.7% as of September 2025. Working capital of ₩93.72 Billion (current assets of ₩101.09 Billion minus current liabilities of ₩7.37 Billion) is measured against net assets of ₩127.11 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cell Biotech Co. Ltd (2012–2024)
Working capital to net assets ratio of Cell Biotech Co. Ltd from 2012 to 2024. This chart shows how Cell Biotech Co. Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 73.7%, reflecting working capital of ₩93.72 Billion against net assets of ₩127.11 Billion KRW. Explore 049960 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cell Biotech Co. Ltd Working Capital to Net Assets Ratio by Year (2012–2024)
Cell Biotech Co. Ltd working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Cell Biotech Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Cell Biotech Co. Ltd's balance sheet.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 73.5% | ₩91.29 Billion | ₩124.17 Billion | ₩97.15 Billion | ₩5.86 Billion | ▲ +4.6 pp |
| 2023 | 68.9% | ₩77.11 Billion | ₩111.89 Billion | ₩81.93 Billion | ₩4.82 Billion | ▲ +5.8 pp |
| 2022 | 63.2% | ₩68.27 Billion | ₩108.09 Billion | ₩75.66 Billion | ₩7.39 Billion | ▲ +5.3 pp |
| 2021 | 57.9% | ₩61.75 Billion | ₩106.69 Billion | ₩67.52 Billion | ₩5.77 Billion | ▼ -2.4 pp |
| 2020 | 60.3% | ₩60.28 Billion | ₩99.98 Billion | ₩64.91 Billion | ₩4.63 Billion | ▼ -2.5 pp |
| 2019 | 62.8% | ₩65.07 Billion | ₩103.60 Billion | ₩69.26 Billion | ₩4.19 Billion | ▼ -7.9 pp |
| 2018 | 70.7% | ₩74.65 Billion | ₩105.62 Billion | ₩81.05 Billion | ₩6.40 Billion | ▼ -1.0 pp |
| 2017 | 71.6% | ₩64.61 Billion | ₩90.20 Billion | ₩70.87 Billion | ₩6.26 Billion | ▼ -3.1 pp |
| 2016 | 74.8% | ₩62.91 Billion | ₩84.15 Billion | ₩69.27 Billion | ₩6.36 Billion | ▲ +5.0 pp |
| 2015 | 69.8% | ₩47.99 Billion | ₩68.76 Billion | ₩54.15 Billion | ₩6.16 Billion | ▲ +5.6 pp |
| 2014 | 64.2% | ₩33.59 Billion | ₩52.36 Billion | ₩38.80 Billion | ₩5.21 Billion | ▲ +6.7 pp |
| 2013 | 57.4% | ₩24.73 Billion | ₩43.05 Billion | ₩28.34 Billion | ₩3.61 Billion | ▼ -5.3 pp |
| 2012 | 62.7% | ₩22.84 Billion | ₩36.42 Billion | ₩26.73 Billion | ₩3.88 Billion | — |